[go: up one dir, main page]

MXPA06000774A - E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados. - Google Patents

E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados.

Info

Publication number
MXPA06000774A
MXPA06000774A MXPA06000774A MXPA06000774A MXPA06000774A MX PA06000774 A MXPA06000774 A MX PA06000774A MX PA06000774 A MXPA06000774 A MX PA06000774A MX PA06000774 A MXPA06000774 A MX PA06000774A MX PA06000774 A MXPA06000774 A MX PA06000774A
Authority
MX
Mexico
Prior art keywords
pyrazolo
pyrimidines
nitro
substituted
compounds
Prior art date
Application number
MXPA06000774A
Other languages
English (en)
Inventor
Marta Princep
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200301747A external-priority patent/ES2222814B1/es
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of MXPA06000774A publication Critical patent/MXPA06000774A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion se refiere a compuestos de la Formula (I), en donde R1 es como se define en las reivindicaciones. Los compuestos tienen afinidad especifica para el receptor GABAA y por tanto son utiles en el tratamiento y prevencion de enfermedades moduladas por a1- y a2GABAA.
MXPA06000774A 2003-07-24 2004-07-22 E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados. MXPA06000774A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200301747A ES2222814B1 (es) 2003-07-24 2003-07-24 3-nitro-pirazolo(1,5-a)pirimidinas 7-sustituidas y composiciones y metodos relacionados.
ES200401696A ES2245893B1 (es) 2003-07-24 2004-07-12 Mejoras en el objeto de la patente de invencion n.p200301747 que se refiere a "3-nitro-pirazolo(1,5-a)pirimidinas 7-sustituidas y composiciones y metodos relacionados".
PCT/EP2004/008207 WO2005014596A1 (en) 2003-07-24 2004-07-22 7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines

Publications (1)

Publication Number Publication Date
MXPA06000774A true MXPA06000774A (es) 2006-04-18

Family

ID=34137683

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000774A MXPA06000774A (es) 2003-07-24 2004-07-22 E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados.

Country Status (15)

Country Link
US (1) US20070043064A1 (es)
EP (1) EP1648896B1 (es)
JP (1) JP2006528607A (es)
KR (1) KR20060030907A (es)
AT (1) ATE386040T1 (es)
AU (1) AU2004263277A1 (es)
BR (1) BRPI0412837A (es)
CA (1) CA2532431A1 (es)
DE (1) DE602004011780D1 (es)
HR (1) HRP20060008A2 (es)
MX (1) MXPA06000774A (es)
NO (1) NO20060586L (es)
TW (1) TWI252851B (es)
UY (1) UY28439A1 (es)
WO (1) WO2005014596A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005108401A1 (en) * 2004-04-29 2005-11-17 Dov Pharmaceutical, Inc. 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones
EP1884516A1 (en) * 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
GB201223308D0 (en) 2012-12-21 2013-02-06 Univ Sunderland Enzyme inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792533A (fr) * 1971-12-09 1973-06-08 Int Chem & Nuclear Corp Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
EP0264773A1 (en) * 1986-10-16 1988-04-27 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines
DE4333705C2 (de) * 1993-10-02 2003-10-30 Guenter Ege Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
US5538977A (en) * 1995-03-17 1996-07-23 American Cyanamid Company 3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines
AU4203500A (en) * 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
DE10153344A1 (de) * 2001-10-29 2003-05-15 Gruenenthal Gmbh Verwendung von substituierten Pyrazolopyrimidinen als Liganden von Nucleosid-Transport-Proteinen und/oder von Purinorezeptoren

Also Published As

Publication number Publication date
JP2006528607A (ja) 2006-12-21
UY28439A1 (es) 2004-11-08
TWI252851B (en) 2006-04-11
NO20060586L (no) 2006-02-06
TW200504074A (en) 2005-02-01
ATE386040T1 (de) 2008-03-15
AU2004263277A1 (en) 2005-02-17
DE602004011780D1 (de) 2008-03-27
BRPI0412837A (pt) 2006-09-26
CA2532431A1 (en) 2005-02-17
WO2005014596A1 (en) 2005-02-17
EP1648896A1 (en) 2006-04-26
HRP20060008A2 (en) 2006-07-31
EP1648896B1 (en) 2008-02-13
KR20060030907A (ko) 2006-04-11
US20070043064A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
CR9389A (es) Compuestos de imidazopiridazina
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
UA83311C2 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
TW200624432A (en) Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
UA83917C2 (en) 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
DE60327375D1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
UA90659C2 (ru) Аналоги хиназолина как ингибиторы рецепторных тирозинкиназ
TW200510422A (en) N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides and compositions and methods related thereto
TW200626600A (en) Octahydropyrrolo[3, 4-c]pyrrole derivatives
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
MXPA06000774A (es) E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados.
TNSN05324A1 (en) 7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines
UA81464C2 (en) NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
TW200640929A (en) N-[3-(8-substituted-imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-sulfonamides, n-[3-(8-substituted-imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides, compositions, and methods related thereto
TNSN05325A1 (en) N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO
TNSN05276A1 (fr) 5,7-diaminopyrazolo[4,3-d] pyrimidines utiles dans le traitement de l'hypertension
UA83142C2 (en) 3-aminocyclopentane carboxyamidine as modulators of chemokine receptors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal